Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “Enanta Pharmaceuticals, Inc.”

218 pharma patents match "Enanta Pharmaceuticals, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 218
Index total 30,257
Page 7 / 10

Quick answer

This filtered view shows 218 pharmaceutical patents matching "Enanta Pharmaceuticals, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

218 results for “Enanta Pharmaceuticals, Inc.” · 30,257 patents in full index Clear search

  1. US 8426458

    Hepatitis C Virus inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Apr 23, 2013 · Expires Apr 18, 2033

    granted

  2. US 8420686

    Linked diimidazole antivirals

    Enanta Pharmaceuticals, Inc. · Granted Apr 16, 2013 · Expires Apr 11, 2033

    granted

  3. US 8420596

    Macrocyclic hepatitis C serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Apr 16, 2013 · Expires Apr 11, 2033

    granted

  4. US 8383583

    Macrocyclic, pyridazinone-containing hepatitis C serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Feb 26, 2013 · Expires Feb 21, 2033

    granted

  5. US 8383785

    Anti-bacterial activity of 9-hydroxy derivatives of 6,11-bicyclolides

    Enanta Pharmaceuticals, Inc. · Granted Feb 26, 2013 · Expires Feb 21, 2033

    granted

  6. US 8377872

    Cyclic P3 tripeptide hepatitis C serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Feb 19, 2013 · Expires Feb 14, 2033

    granted

  7. US 8372802

    Fluorinated macrocyclic compounds as hepatitis C virus inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Feb 12, 2013 · Expires Feb 7, 2033

    granted

  8. US 8367618

    Cyclosporin analogues for preventing or treating hepatitis C infection

    Enanta Pharmaceuticals, Inc. · Granted Feb 5, 2013 · Expires Jan 31, 2033

    granted

  9. US 8367053

    Cyclosporin analogues

    Enanta Pharmaceuticals, Inc. · Granted Feb 5, 2013 · Expires Jan 31, 2033

    granted

  10. US 8361958

    Oximyl HCV serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Jan 29, 2013 · Expires Jan 24, 2033

    granted

  11. US 8354383

    6,11-bridged biaryl macrolides

    Enanta Pharmaceuticals, Inc. · Granted Jan 15, 2013 · Expires Jan 10, 2033

    granted

  12. US 8349312

    Proline substituted cyclosporin analogues

    Enanta Pharmaceuticals, Inc. · Granted Jan 8, 2013 · Expires Jan 3, 2033

    granted

  13. US 8324155

    Quinoxaline-containing compounds as hepatitis C virus inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Dec 4, 2012 · Expires Nov 29, 2032

    granted

  14. US 8314135

    Linked dibenzimidazole antivirals

    Enanta Pharmaceuticals, Inc. · Granted Nov 20, 2012 · Expires Nov 15, 2032

    granted

  15. US 8304385

    Macrocyclic tetrazolyl hepatitis C serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Nov 6, 2012 · Expires Nov 1, 2032

    granted

  16. US 8283309

    Bridged carbocyclic oxime hepatitis C virus serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Oct 9, 2012 · Expires Oct 4, 2032

    granted

  17. US 8273709

    Triazole-containing macrocyclic HCV serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Sep 25, 2012 · Expires Sep 20, 2032

    granted

  18. US 8268776

    Macrocylic oximyl hepatitis C protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Sep 18, 2012 · Expires Sep 13, 2032

    granted

  19. US 8268777

    Oximyl macrocyclic derivatives

    Enanta Pharmaceuticals, Inc. · Granted Sep 18, 2012 · Expires Sep 13, 2032

    granted

  20. US 8263549

    C5-substituted, proline-derived, macrocyclic hepatitis C serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Sep 11, 2012 · Expires Sep 6, 2032

    granted

  21. US 8242156

    Linked dibenzimidazole derivatives

    Enanta Pharmaceuticals, Inc. · Granted Aug 14, 2012 · Expires Aug 9, 2032

    granted

  22. US 8236807

    Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Aug 7, 2012 · Expires Aug 2, 2032

    granted

  23. US 8221737

    Hepatitis C virus inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Jul 17, 2012 · Expires Jul 12, 2032

    granted

  24. US 8222203

    Macrocyclic oximyl hepatitis C serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Jul 17, 2012 · Expires Jul 12, 2032

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.